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Photoprotection by 1,25 Dihydroxyvitamin D3 Is
Associated with an Increase in p53 and a Decrease in
Nitric Oxide Products
Ritu Gupta1,4, Katie M. Dixon1,4, Shivashni S. Deo1, Carolyn J. Holliday1, Michael Slater1, Gary M. Halliday2,
Vivienne E. Reeve3 and Rebecca S. Mason1
Vitamin D is produced in skin by UVB radiation (290–320 nm) acting on 7-dehydrocholesterol. The hypotheses
that the active vitamin D hormone, 1,25 dihydroxyvitamin D3 (1,25(OH)2D3), would increase the survival of skin
cells after UV irradiation and that surviving cells after 1,25(OH)2D3 treatment would have no increase in DNA
damage were tested. The survival of keratinocytes post-UVR was significantly greater after treatment with
1,25(OH)2D3 compared to vehicle (Po0.01). Significant reductions in thymine dimers (TDs) in surviving
keratinocytes after UVR were noted in the presence of 1,25(OH)2D3 (Po0.001). Nuclear p53 protein expression
increased after UVR and was significantly higher in keratinocytes treated with 1,25(OH)2D3 (Po0.01), whereas
NO products were significantly reduced (Po0.05). Both the increase in nuclear accumulation of p53 protein and
reduced formation of nitric oxide products may contribute to the reduction in TDs seen with 1,25(OH)2D3 after
UVR. Reductions in numbers of sunburn cells (Po0.01) and in TDs (Po0.05) were observed 24 hours after UVR
in skin sections from Skh:hr1 mice treated with 1,25(OH)2D3. These results are consistent with the proposal that
the vitamin D system in skin may be part of an intrinsic protective mechanism against UV damage.
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INTRODUCTION
UVR interacts with 7-dehydrocholesterol in the keratinocyte
to form pre-vitamin D3 which at body temperature, thermally
isomerizes into vitamin D3 (Holick, 1994). Vitamin D3
metabolites, 25 hydroxyvitamin D3 and 1,25 dihydroxyvita-
min D3 (1,25(OH)2D3) are also produced locally in skin cells
(Bikle et al., 1986; Matsumoto et al., 1991; Lehmann et al.,
2000, 2001), although their function in skin is not fully
understood. The normal differentiation of keratinocytes is
partly regulated by 1,25(OH)2D3 (Pillai et al., 1988a), as is
hair follicle development (Reichrath, 2000) and, under some
circumstances, 1,25(OH)2D3 can enhance pigmentary res-
ponses (Mason, 2000).
In earlier cell culture studies, we and others have shown
that treatment with 1,25(OH)2D3 results in increased
cornified envelope formation in keratinocytes (Holliday
et al., 1997; Pillai et al., 1988a, b) and in increased
melanogenesis in melanocytes (Ranson et al., 1988). As two
of the features of normal cellular responses to UVR in vivo as
well as in vitro are increased cornification of keratinocytes
and increased pigment production by melanocytes (Dissa-
nayake et al., 1993), we were interested in the responses of
skin cells to UVR in the presence of 1,25(OH)2D3. There has
been some evidence to suggest that 1,25(OH)2D3 may
enhance keratinocyte survival after UVR exposure (Koren
et al., 2000b; Manggau et al., 2001). This is in contrast to the
ability of 1,25(OH)2D3 to increase susceptibility of tumor
cells to apoptosis-inducing agents (Kasukabe et al., 1987;
Holliday et al., 1997; Koren et al., 2000a).
It is well accepted that UVR directly interacts with DNA
causing DNA damage, for example, thymine dimer (TD)
formation (Setlow, 1966). UVR induces high levels of the p53
tumor suppressor protein, mainly through post-translational
stabilization of the protein (Hall et al., 1993). In turn, p53
activates the transcription of downstream genes responsible
for cell cycle arrest. This growth arrest allows for repair of
DNA damage, a process facilitated by increased p53 (Smith
et al., 1995). However, p53 can also cause apoptosis of cells
with excessive unrepaired DNA damage (Decraene et al.,
2001). UVR also increases nitric oxide (NO) products which
may contribute to UVR-induced DNA damage and inhibit
DNA repair (Jaiswal et al., 2000; Bau et al., 2001). In human
islet cells treated with cytokines and in rat hippocampus
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injected with lipopolysaccharide, 1,25(OH)2D3 had been
reported to reduce apoptosis through a decrease in NO
products (Garcion et al., 1998; Riachy et al., 2002).
A key question is whether 1,25(OH)2D3 allows cells with
increased DNA damage to survive. Preliminary evidence
indicates that this is not the case (Wong et al., 2004; De Haes
et al., 2005). In this study, we show that UVR-induced
cyclobutane pyrimidine dimers are reduced, not increased,
after 1,25(OH)2D3 treatment and propose a novel mechanism
for this involving enhanced elevation of nuclear p53 post-
UVR and suppression of the NO pathway. Increased cell
survival and reduced DNA damage were also seen in skin of
UV-irradiated Skh:hr1 hairless mice after topical treatment
with 1,25(OH)2D3. Thus, vitamin D production may be a
photoprotective mechanism of the skin that increases skin
cell survival after UVR without an increase in DNA damage.
RESULTS
Cell numbers
The protective effect of 1,25(OH)2D3 and related compounds
on UV-induced keratinocyte apoptosis has been described by
a number of groups, including our own (Hanada et al., 1995;
Holliday et al., 1997; Lee and Youn, 1998; Koren et al.,
2000b; Manggau et al., 2001; De Haes et al., 2003, 2004;
Wong et al., 2004), although the concentrations of
1,25(OH)2D3 used by some groups to achieve this were
often high. When keratinocytes were pretreated with
1,25(OH)2D3, cell survival was significantly and dose-
dependently increased from 6871% (SEM) to 8471%
(Po0.01) (Figure 1). A protective effect by 1,25(OH)2D3
was seen in skin cells from more than 10 donors.
Similar results were seen in separate experiments using
keratinocytes derived from sun-exposed skin on the back of a
female subject –keratinocyte survival 24 hours post-UVR was
47712% (SD) in vehicle-treated wells, this was increased to
65720% in keratinocytes treated with 109 M 1,25(OH)2D3
(Po0.05) and 100736% in cells treated with 108 M
1,25(OH)2D3 (Po0.01) (Figure S1). In separate experiments,
a significant photoprotective effect on cell survival was also
noted when 1,25(OH)2D3 was added immediately after UVR,
and cell survival was not different to that in irradiated cells
treated with 1,25(OH)2D3 24 hours earlier. Percentage cell
survival increased from 61712% (SD) to 85722% (Po0.01)
in cells treated with 1,25(OH)2D3 for 24 hours before UV,
and to 81717% (Po0.01) in cells treated immediately after
irradiation only.
Treatment with a non-active analog, 1a,25-dihydroxyta-
chysterol3, JB, (Norman et al., 2001) did not significantly alter
keratinocyte numbers after UVR exposure in experiments
where the active compound significantly enhanced cell
survival after UVR (vehicle 67714% (SD), JB 65720%;
P¼not significant, Figure S2).
As noted earlier, the vitamin D hormone, 1,25(OH)2D3,
enhances epidermal cell differentiation and inhibits prolife-
ration. To investigate whether this reduced skin cell
proliferation might explain the enhanced survival in cell
numbers after UVR, we tested whether there was a
correlation between the reduction in keratinocyte numbers
induced by 1,25(OH)2D3 in the sham-irradiated group and
the degree of protection from UVR-induced cell death. No
significant correlations were found (r2¼0.46, n¼10,
P40.05) showing that the capacity of 1,25(OH)2D3 to
prevent UVR-induced reductions in skin cell numbers is not
explained by its ability to reduce cell proliferation (Figure S3).
Sunburn cells in mouse skin
Treatment with 1,25(OH)2D3 immediately post-UVR also
reduced the number of sunburn cells (apoptotic keratinocytes)
in Skh:hr 1 mice. The mean number of sunburn cells per linear
millimeter in vehicle-treated skin was 2.070.7 (SD). This was
reduced to 1.470.2 in mice treated with 1,25(OH)2D3 at a
concentration of 22.8 pmol/cm2 (Po0.05), and to 1.270.2 at a
concentration of 45.6 pmol/cm2 (Po0.01).
Thymine dimers
Exposure to UVR results in TD which can be detected in
irradiated skin cells using a specific monoclonal antibody to
TDs (Roza et al., 1988). Figure 2 shows very little staining in
sham-irradiated control, but much increased staining after
UVR in vehicle-treated wells. Figure 3a shows a dose-
dependent decrease in TD 3 hours after UVR in
1,25(OH)2D3-treated keratinocytes from neonatal foreskins
(Figure 3a). In separate experiments, similar reductions in
cyclobutane pyrimidine dimers were seen in keratinocytes
derived from the back of a female subject, where cyclobutane
pyrimidine dimer-positive nuclei, as percent total nuclei, at
3 hours after irradiation were 57713% (SD) in vehicle-
treated cultures but only 1275% in keratinocytes treated
with 109 M 1,25(OH)2D3 (Po0.001) and 1372% in cells
treated with 108 M 1,25(OH)2D3 (Po0.001, Figure S4).
In a separate time course study, mean TDs were
significantly reduced by 109 M 1,25(OH)2D3 pretreatment
at 0.5, 3 (Po0.05), and 6 hours (Po0.01) after UVR in
keratinocytes. A similar reduction, although not statistically
significant, was also observed at 24 hours after UVR
(Figure 3b). No significant differences in TD were seen in
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Figure 1. 1,25(OH)2D3 increases keratinocyte survival after UVR. Cells were
preincubated with 1,25(OH)2D3 at doses ranging from 10
11 to 107 M or
with vehicle for 24 hours before irradiation in buffer solution. 1,25(OH)2D3
was replaced after irradiation and cells counted 24 hours after UVR. Each
point represents mean7SEM of normalized data from six data points from two
independent experiments. Significantly different from vehicle: **Po0.01,
*Po0.05.
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the presence of 1,25(OH)2D3 or vehicle in cells examined
immediately after UVR. Very few TD were present by
48 hours.
In separate experiments, treatment with 109 M
1,25(OH)2D3 immediately post-UVR only, also significantly
reduced TD at 3 hours from a mean of 1876% (SD) in
vehicle-treated cultures to 871%, (Po0.01). Treatment with
the inactive analog, JB, did not reduce TD-positive nuclei as a
percentage of total nuclei in keratinocytes. The respective
values were vehicle, 1976% (SD); 1,25(OH)2D3, 471%
(Po0.01); JB, 17710% (P¼not significant, Figure S5).
Recent studies by our group have shown a reduction in
TD, measured 24 hours after UVR in the skin of Skh:hr 1 mice
treated with topical 1,25(OH)2D3 24 hours before and
immediately after UVR (Dixon et al., 2005). In this study,
the level of nuclear TD staining was also reduced in mouse
skin treated only immediately post-UVR with 1,25(OH)2D3
compared with vehicle-treated mice, measured 24 hours after
UVR (Figure 4). Mean TD-positive nuclei, as percent total
nuclei, was 2276% (SD) in vehicle-treated mouse skin,
reduced to 973% in mouse skin treated with 1,25(OH)2D3
immediately post-UVR at a dose of 22.8 pmol/cm2 (Po0.05).
p53 expression
Only a few nuclei in sham-irradiated keratinocytes stained
positively for p53 protein, with no differences between
vehicle- or 1,25(OH)2D3-treated cultures. Nuclear staining
increased markedly after UVR in all cultures, but to a much
greater extent in cells treated with 1,25(OH)2D3 (Figure S6).
There was no p53 staining in the cytoplasm and all p53
staining was expressed as positive nuclei as percent of total
nuclei. As shown in Figure 5a, p53 staining at 3 hours post-
UVR increased 3- to 5-fold in irradiated keratinocytes treated
for 24 hours with 1,25(OH)2D3, compared with vehicle-
treated cultures (Po0.05). By 6 hours after UVR, p53 staining
was around 9-fold higher in the vehicle-treated keratinocytes
than at 3 hours (Po0.001), but was still significantly higher in
the cultures treated with 1,25(OH)2D3 compared with
vehicle-treated keratinocytes at 6 hours (Po0.01). Where
p53 expression and TD were measured in the same
experiment, there was a reciprocal relationship between the
increase in p53 and the decrease in TD (Figure 5b).
NO pathways
UV irradiation increases NO and its products in skin cells
(Bruch-Gerharz et al., 1998) and may play a role in
enhancing the genotoxic effects of UVR (Suzuki and Inukai,
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Figure 2. 1,25(OH)2D3-induced reduction in TDs in keratinocytes after
UVR. Keratinocytes were treated with vehicle or 1,25(OH)2D3 24 hours
before and immediately after irradiation. Cells were fixed 3 hours post-UVR
and the level of TD measured by immunohistochemistry. A reduction in
TD staining is shown with 1,25(OH)2D3 treatment. Dark arrows ( ) point to
TD-positive nuclei; open arrows ( ) point to TD-negative nuclei. Bar¼ 50 mm.
(a) Vehicle, (b) 1,25(OH)2D3 10
9
M, (c) 1,25(OH)2D3 10
9
M UVR, and
(d) vehicle UVR.
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Figure 3. Dose- and time- dependent reduction of UVR-induced TDs in
Keratinocytes by 1,25(OH)2D3. (a) 1,25(OH)2D3-induced dose-dependent
reduction in keratinocyte TDs after UVR, (b) and time course of reduction in
UVR-induced keratinocyte TDs by 1,25(OH)2D3. (a) Keratinocytes were
preincubated with 1,25(OH)2D3 at doses ranging from 10
11 to 108 M or
with vehicle for 24 hours before irradiation in buffer solution. 1,25(OH)2D3 or
vehicle was replaced after irradiation and immunohistochemistry performed
at 3 hours. The number of positively stained nuclei for TD as a % of the total
nuclei was calculated using light microscopy and image analysis. Results are
presented as mean7SD. The average value of the control in keratinocytes
was 81.6710.6%. Significantly different from vehicle: ***Po0.001,
**Po0.01. Significant difference between doses: ###Po0.001, ##Po0.01,
#Po0.05. (b) Keratinocytes were preincubated with 1,25(OH)2D3 (109 M) or
with vehicle for 24 hours before irradiation in buffer solution. 1,25(OH)2D3 or
vehicle was replaced after irradiation and cells fixed at the indicated time
points for immunohistochemical detection of TD. Each point is normalized to
the 0.5 hours time point and represents the pooled data7SEM from at least six
data points from a minimum of two independent experiments. The average
number of positive nuclei as a percent of total nuclei in the control was
30.379.6%. Significantly different from vehicle at the same time-point by
Student’s t-test: *Po0.05, **Po0.01.
www.jidonline.org 709
R Gupta et al.
1,25 Dihydroxyvitamin D3 and Photoprotection
2006). The Griess reaction showed an increase in the stable
metabolite of NO, nitrite, after UVR in all experiments. In
sham-irradiated control keratinocytes, nitrite concentrations
were 70720 mg/l (SD) nitrite as compared with 180740 mg/l
nitrite after irradiation in control wells (Po0.05). There was a
significant decrease in nitrite after UVR in cells which had
been treated with 1,25(OH)2D3 (9372% of the irradiated
control, Po0.05). This decrease was similar to the reduction
in nitrite seen with a NO synthase inhibitor, aminoguanidine,
in the same experiment (8872% of the irradiated control,
significantly different from vehicle-treated cells, Po0.001).
Because both aminoguanidine and 1,25(OH)2D3 reduced
nitrite in UV-irradiated keratinocytes, aminoguanidine and
another NO synthase inhibitor L-N-monomethylarginine (L-
NMMA) were used to treat keratinocytes immediately after
irradiation. At 3 hours after irradiation, significant decreases
in TD, similar to those with 1,25(OH)2D3 treatment alone,
were observed (Figure 6). In separate experiments, there was
no additional effect of L-NMMA in 1,25(OH)2D3-pretreated
cultures. In pooled data from five experiments, the mean
percentage TD-positive nuclei was 1672% (SEM) in vehicle-
treated keratinocytes and 971% in keratinocytes treated
with 109 M 1,25(OH)2D3 (Po0.01 vs vehicle); 1071% in
keratinocytes treated with 1.28 mM L-NMMA (Po0.01 vs
vehicle) and 771% in keratinocytes treated with 109 M
1,25(OH)2D3 and 1.28 mM L-NMMA (Po0.01 vs vehicle but
not significant vs 1,25(OH)2D3 or L-NMMA alone).
DISCUSSION
The results of this study show photoprotective effects of
1,25(OH)2D3 in vitro and in vivo. 1,25(OH)2D3 increased
keratinocyte survival and decreased sunburn cells probably
as a result of the reduction in detectable DNA damage in the
form of TD from 30 minutes after UVR exposure. The
reduction in TD was associated with an increase in p53
expression and a reduction in NO derivatives.
After the initial report of 1,25(OH)2D3 synthesis in
keratinocytes (Bikle et al., 1986), several studies by Lehmann
et al. (1999, 2000, 2001) have shown evidence of a complete
pathway of vitamin D synthesis from 7-dehydrocholesterol to
the active metabolite, 1,25(OH)2D3 in epidermal cells, skin
equivalents, and living skin. Keratinocytes are prone to
cell damage after UVR, resulting in cell cycle arrest or
apoptotic cell death (Zhai et al., 1996; Lee and Youn, 1998).
a
b c
d e
50 m
Figure 4. 1,25(OH)2D3-induced reduction in TDs in Skh:hr1 mouse skin
after UVR. Mice were exposed to three minimal erythemal doses SSUVR and
treated topically with vehicle or 1,25(OH)2D3 immediately after irradiation.
Skin sections were taken 24 hours post-UVR and the level of TD measured by
immunohistochemistry. A reduction in TD staining is shown with
1,25(OH)2D3 treatment. Dark arrows ( ) point to TD-positive nuclei; open
arrows ( ) point to TD-negative nuclei. Bar¼50 mm. (a) Isotype control,
(b) vehicle, (c) vehicle UVR, (d) 1,25(OH)2D3 22.8 pmol/cm
2, and (e)
1,25(OH)2D3 22.8 pmol/cm
2 UVR.
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Figure 5. Nuclear p53 protein expression after UVR and relationship with
TDs in the presence of 1,25(OH)2D3. (a) 1,25(OH)2D3-induced increase in
p53 protein expression in keratinocytes after UVR, (b) and reciprocal
relationship between p53 and TD expression. Cells were preincubated with
1,25(OH)2D3 at 10
9 or 108 M or with vehicle for 24 hours before irradiation
in buffer solution. 1,25(OH)2D3 or vehicle was replaced after irradiation and
immunohistochemistry and image analysis performed at the indicated times.
(a) An increase in p53 expression with 1,25(OH)2D3 treatment is shown at
3 and at 6 hours after UVR in keratinocytes. The mean7SD for p53-positive
nuclei as % total nuclei in vehicle-treated cells at 3 hours was 1.870.7%.
Significantly different from 3 hours vehicle control: *Po0.05; significantly
different from 6 hours vehicle control: ##Po0.01. (b) An increase in p53 and
concurrent decrease in TD is shown 6 hours after UVR in cells treated
with 1,25(OH)2D3. The mean7SD for positive nuclei as % total nuclei in
vehicle-treated cells was 10.976.3% for p53 and 27.274.0% for TD. p53
expression significantly different from vehicle **Po0.01, *Po0.05; TD
expression significantly different from vehicle ###Po0.001, ##Po0.01.
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Treatment with 1,25(OH)2D3 improved cell survival after
UVR compared with sham-irradiated cultures. The effect was
concentration-dependent, and even occurred when the
1,25(OH)2D3 was added immediately after UVR. Increased
cell survival was achieved at concentrations of 1,25(OH)2D3
that were much lower than those reported by other groups
(Manggau et al., 2001; De Haes et al., 2003, 2004). The
concentrations used in our study are likely to be achieved in
skin. In general, basal 7-dehydrocholesterol content in
cultured keratinocytes and skin equivalents is very low
compared to that present in living skin (Nemanic et al.,
1985). The low concentration of 7-dehydrocholesterol in
cultured skin cells and the relatively long time required to
produce 1,25(OH)2D3 after UVR in vitro or in vivo (Lehmann
et al., 2001) help to explain the dramatic effects noted when
1,25(OH)2D3 was added to the system. UVB irradiation has
been reported to induce expression of vitamin D-25-
hydroxylase in keratinocytes in human skin equivalents
(Lehmann et al., 1999). Based on the production rates
demonstrated in human skin equivalents and in human skin
using microdialysis (Lehmann et al., 2000, 2001), it can be
calculated that local concentrations of 1,25(OH)2D3 in the
order of 2–5 nM might be reasonably achieved. The photo-
protective effects demonstrated in this study were achieved
with concentrations of 1,25(OH)2D3 of this order of
magnitude and even lower.
There have been preliminary reports of reduced sunburn
cell formation in vivo after UVR in mouse skin treated with
1,25(OH)2D3 (Hanada et al., 1995; Lee and Youn, 1998).
Confirming the cell culture studies, a dose-dependent
decrease in sunburn cells in mice treated topically with
1,25(OH)2D3 was seen in this study. One potential concern
with the 1,25(OH)2D3-induced increase in the survival of
skin cells after UVR, is that the treatment might have allowed
more cells with DNA damage to survive. In fact, a dose-
dependent decrease in TD was seen, which is likely to have
resulted in the survival of a greater number of cells. The
reduction in TD was also confirmed in mice. It should be
noted, however, that the majority of cells did not have DNA
damage and the effects on survival were an improvement of a
few percent. Furthermore, a reduction in TD at some time
point after irradiation does not necessarily reduce mutation
frequency after UVR, if for example, 1,25(OH)2D3 induces an
error-prone DNA repair system. This cannot be readily
tested in a short-term cell culture system. Nevertheless,
1,25(OH)2D3 has been shown to inhibit multistage chemical-
induced skin carcinogenesis in mice (Wood et al., 1983), and
more recently, novel analogs of vitamin D have been shown
to have similar effects (Kensler et al., 2000). Furthermore,
VDR/ mice have been reported to have enhanced
sensitivity to chemically induced skin tumorigenesis com-
pared to wild-type (VDRþ /þ ) mice (Zinser et al., 2002).
Two pieces of evidence indicate that the protective effect
of 1,25(OH)2D3 cannot be merely owing to the compound
acting as a UV absorber. These include the demonstration
that even when 1,25(OH)2D3 was only added after irradia-
tion, it still caused a significant reduction in keratinocyte
losses and UVR-induced TD and the observation that the
inactive compound JB failed to show any photoprotective
activity, even though it absorbs in the UVB range, although to
a lesser extent than 1,25(OH)2D3.
The p53 tumor suppressor gene is considered the
‘‘guardian of the genome’’. Following UVR, the amount of
p53 protein in the nucleus of skin cells becomes elevated
(Ouhtit et al., 2000). The elevated p53 induces cell cycle
arrest, allowing DNA repair, and appears also to directly
contribute to enhanced nucleotide excision repair (Smith
et al., 1995; Li et al., 1996). If the DNA damage is excessive
or unrepaired, the elevated p53 can also cause apoptosis by
upregulation of Bax and/or downregulation of Bcl-2 expres-
sion (Ouhtit et al., 2000). UVR-induced apoptosis indepen-
dent of p53 has also been described (Li et al., 1996).
Previously, 1,25(OH)2D3, has been shown to have no effect
on p53 expression in non-irradiated normal cultures of
human keratinocytes (Sebag et al., 1994). A study that used
a high dose of 1,25(OH)2D3 (10
6
M) reported that surpris-
ingly, 1,25(OH)2D3 treatment of irradiated keratinocytes led
to an increase in Bcl-2 expression occurring in conjunction
with a decrease in p53 expression following UVR (De Haes
et al., 2004). The work presented here provides evidence that
1,25(OH)2D3 markedly enhances nuclear p53 protein ex-
pression in irradiated keratinocytes. Apart from dose effects, it
is not clear why there is a divergence in results, as the
biological systems in the two studies were similar. One
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Figure 6. 1,25(OH)2D3 and NO inhibitors L-NMMA and aminoguanidine,
added after UVR induce a reduction in TDs. Keratinocytes were irradiated in
buffer solution. 1,25(OH)2D3 or vehicle in medium was added to
quadruplicate wells after irradiation whereas others received L-NMMA
(1.28 mM) or aminoguanidine (2 mM). Cells were incubated in the above
solutions for 3 hours post-UVR after which immunohistochemistry was
performed. The number of positively stained nuclei for TD as a % of the total
nuclei was calculated using light microscopy and image analysis. Significant
differences compared to vehicle with Student’s t-test are: **Po0.01,
*Po0.05.
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possibility is that in this study, the keratinocytes were
incubated without EGF and cholera toxin for 2 days to
reduce overstimulation of cell signal pathways before
irradiation.
The further increase in p53 with 1,25(OH)2D3 post-UVR
may well be an important mechanism of enhanced DNA
repair in the vitamin D-treated cells (Smith et al., 1995;
Li et al., 1996). A decrease in UVR-induced DNA damage by
the agent silibinin has also been reported to be associated
with an increase in p53 accumulation in Skh:hr1 mice
(Dhanalakshmi et al., 2004). The decrease in TD with
1,25(OH)2D3 was very marked. This is perhaps surprising
as the rate of repair of pyrimidine dimers is relatively slow,
with a half-life of around 7 hours (Mitchell et al., 1990;
Yarosh and Yee, 1990; Katiyar, 2000), although the culture
process may select for more rapidly replicating, repair-
proficient cells (Mitchell et al., 1990). Interestingly, the study
using topical silibinin before or immediately after UV
exposure also reported comparable decreases in TD
(76–86% reduction) at 1 hour after UVR. The authors
speculated that the protective efficacy of silibinin against
UV-induced tumor initiation might be owing to an inhibition
in UV-induced DNA damage. The time course data reported
here are consistent with this proposal. Metabolic induction of
pyrimidine dimers has been reported (Lamola, 1971).
Studies by Ravid et al. (2002) and De Haes et al. (2003), as
well as preliminary studies by our group (data not shown)
have shown that photoprotection by 1,25(OH)2D3 involves
inhibition of c-Jun-(NH)2-terminal kinase activity, leading to
increased cell survival after UVR. It has recently been
reported that the prosurvival activity of p53 involves its
ability to bind and inhibit the activity of c-Jun-(NH)2-terminal
kinase, and subsequent inhibition of its role in mitochondrial
death signaling (Lo et al., 2004). This mechanism is consistent
with our results which show upregulation of p53 by
1,25(OH)2D3.
Another mechanism may also contribute to increased
DNA repair. NO and peroxynitrite are well known to be
increased after UVR (Bruch-Gerharz et al., 1998). NO is
converted to the toxic free radical, peroxynitrite (Beckman
and Koppenol, 1996; Ischiropoulos, 1998). Recently, NO and
NO donors have been shown to inhibit TD repair through the
inhibition of TD excision (Jaiswal et al., 2000; Bau et al.,
2001). Conversely, NO synthase inhibitors have been
reported to enhance DNA repair in the presence of arsenite
(Bau et al., 2001). Aminoguanidine and a second NO
synthase inhibitor, L-NMMA, reduced TDs and nitrite in
irradiated keratinocytes to an extent similar to that seen with
1,25(OH)2D3. L-NMMA, and 1,25(OH)2D3 did not augment
each other’s activity. These results, and those showing no
reduction in TD immediately after UVR in the presence of
1,25(OH)2D3, are consistent with a hypothesis that the action
of 1,25(OH)2D3 to reduce TD damage after UVR may be
partly due to a decrease in NO products leading to an
increase in TD repair. In this context, it is worth noting,
although the evidence is circumstantial, that enhanced TD
repair leads to reduced UVR-induced immunosuppression
(Kripke et al., 1992) as does topical application of NO
inhibitors (Kuchel et al., 2003). In a preliminary publication,
we have reported that 1,25(OH)2D3 reduces UVR-induced
immunosuppression in mice (Dixon et al., 2005).
The active metabolite of vitamin D is best known for its
ability to enhance gut calcium and phosphate absorption to
provide mineral for bone, although actions in many tissues
are now established. The data presented here are consistent
with the proposal that the production and accumulation of
vitamin D in skin by UVR and its likely conversion locally
over time to 1,25(OH)2D3 will enhance UVR-induced p53
protein expression and suppress NO and its derivatives,
resulting in increased DNA repair. This photoprotective
mechanism increases skin cell survival after UVR without
an increase in DNA damage in vitro and in vivo. The
possibility of using vitamin D compounds before or after UV
irradiation to reduce skin damage is a potential avenue for
investigation.
MATERIALS AND METHODS
Materials
Tissue culture media and phosphate-buffered saline were purchased
from TRACE Biosciences Pty. Ltd (Castle Hill, Australia).
1,25(OH)2D3 was provided by Roche Products (DeeWhy, Australia)
and was also purchased from Sigma Chemical Company (St Louis,
MO). Fetal bovine serum was from Commonwealth Serum
Laboratories (Sydney, N.S.W., Australia). Multiwell plates, chamber-
well slides, and glass coverslips were from Becton Dickinson
Labware (Franklin Lakes, NJ), Nunc (Naperville, IL), and Menzel-
Glaser (Braunschweig, Germany), respectively. Pronectin-coated
culture plates were from ICN Biomedicals Australasia Pty. Ltd
(Sydney, Australia). All other chemicals and hormones were
obtained from Sigma (St Louis, MO), unless otherwise indicated.
Cell culture
The studies of human tissue were approved by the Human Research
Ethics Committee of the University of Sydney and were conducted
according to the Declaration of Helsinki Principles. All subjects or
their legal guardians gave written informed consent. Keratinocytes
were cultured from human neonatal foreskins from Caucasian
donors as described previously by Gordon-Thomson et al. (2001)
with some modifications. Keratinocytes were also grown from skin
removed from the back of a female donor at elective surgery. Briefly,
skin was washed in phosphate-buffered saline, cut into cubes, and
immersed in 0.1% dispase (w/v) overnight at 41C. The epidermal
sheet was removed and incubated in 0.1% trypsin and 0.02% EDTA
at 371C until a cell suspension was formed. The resulting cell
suspension was centrifuged and resuspended in low calcium
medium (DMEM without calcium) with 30 mg/l penicillin, 50 mg/l
streptomycin, 2.2 g/l NaHCO3, 293 mg/l glutamine, 2.385 g/l
(10 mM) N-2-hydroxyethylpiperazine-N0-2-ethanesulfonic acid buf-
fer, 10 ng/ml EGF, 1010 M cholera toxin, 0.5 mg/l hydrocortisone,
and 5% v/v heat-inactivated fetal bovine serum as described
previously (Dissanayake et al., 1993).
Cells were used at passages 1–6. For experiments, cells were
plated on poly-L-lysine-coated multiwell plates, chamber-well slides,
or on glass coverslips and then treated with ethanol vehicle (0.1%) or
1,25(OH)2D3 at 10
11 to 108 M dissolved in ethanol 0.1% v/v,
unless otherwise stated. For cell survival studies, keratinocytes were
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plated onto 24- or 96-well culture plates. For TD experiments, cells
were plated onto poly-L-lysine-coated 5 mm glass coverslips in 96-
well plates.
Experiments were carried out at approximately 60–80% con-
fluence and the media changed to DMEM without EGF and cholera
toxin for at least 2 days before experiments to allow cell signal
pathways to normalize (McLeod et al., 1995). Pretreatment with
vehicle or 1,25(OH)2D3 was for 24 hours, unless otherwise
indicated.
Irradiation
The UV source consisted of a FS20T12 UVB lamp and a FL20SBL
UVA lamp (Philips, Amsterdam, Holland) filtered through a 0.5 mm
layer of cellulose tri-acetate (Eastman Chemical Products, Kingsport,
TN) to remove wavelengths below 290 nm. This filter also markedly
reduced irradiance of the more energetic UVB wavelengths (Figures
S1–S7). Irradiance was 200 mJ/cm2 UVB and 1,170 mJ/cm2 UVA.
Irradiance was checked regularly with an OL754 radiometer
(Optronics Laboratories Inc., Orlando, FL) calibrated against the
source just before irradiation. Media was changed to phosphate-
buffered saline or to a Martinez buffer solution containing 145 mM
NaCl, 5.5 mM KCl, 1.2 mM MgCl2 6H2O, 1.2 mM NaH2PO4 2H2O,
7.5 mM Na-N-2-hydroxyethylpiperazine-N0-2-ethanesulfonic acid,
10 mM D-glucose, and 1 mM CaCl2  2H2O as indicated. After
irradiation, the buffer solution was replaced with media containing
vehicle or 1,25(OH)2D3 for 24 hours unless otherwise stated, when
remaining viable cells were counted or fixed for immunohistochem-
istry assays. Sham-irradiated cells were subjected to similar
procedures but were shielded during the irradiation.
Cell counts
Cells were recovered by trypsinization at 24 hours after UVR unless
otherwise stated and counted using a hemocytometer (Fuchs
Rosenthall model) obtained from Weber Scientific International Ltd
(Sussex, UK). Trypan blue exclusion was used to determine live cell
numbers, which were used in results. Percentage cell survival was
calculated by dividing the mean live cell number in irradiated wells
by the mean live cell number in sham-irradiated control wells
treated with the same dose of test substance.
Immunohistochemistry
Cells were fixed at 3 hours after UV irradiation, unless otherwise
indicated. Fixation was achieved using 100% methanol at 201C.
H2O2 (1%) diluted in phosphate-buffered saline (v/v) was used to
block endogenous peroxidase. Antigen retrieval involved nuclear
DNA denaturation with 70 mM NaOH diluted in 70% ethanol,
followed by proteolytic digestion with Proteinase K 1 mg/ml. Non-
specific staining was blocked with 50% normal human serum
diluted in phosphate-buffered saline. Immunohistochemistry was
performed using the Dakocytomation LSAB Plus kit (Glostrup,
Denmark) with mouse monoclonal IgG1, lambda anti-TD antibody
(Affitech, Oslo, Norway) for TD detection (Roza et al., 1988) or the
D07 mouse monoclonal IgG2b, kappa antibody (Dakocytomation,
Glostrup, Denmark) for detection of p53. To control for specificity of
the primary antibody, isotype controls at the same protein
concentration were used. This resulted in no staining. The
chromogen diaminobenzidine was used for visualization of kerati-
nocytes (Dakocytomation).
Image analysis
Slides were examined under a Zeiss-Axioplan light microscope at
 10 original magnification. Areas from both sham-irradiated
coverslips and UV-irradiated coverslips were randomly captured
using a Sony Progressive color CCD camera (Sony, Tokyo, Japan)
and transferred to a Zeiss KS400 (Carl Zeiss Vision, Munich,
Germany) image analysis system.
Before capturing the images, light intensity was adjusted to a
standard setting that remained the same throughout the image
analysis process. One image was captured from each sham-
irradiated coverslip and two from each UV-irradiated coverslip.
The images taken from the sham-irradiated coverslips were used to
set the thresholds for comparison of UV-irradiated coverslips. Two
measurements were recorded from each image: total nuclei, and
positively stained nuclei. The positively stained nuclei could be
easily differentiated from all other nuclei according to their density
and thus they were identified in the image analysis program by a
combination of grayscale thresholding and manual editing. The
parameters measured were area and grayscale density.
Griess assay
This assay quantifies nitrite (a stable metabolite of NO) in solution.
The Griess assay is based on diazotization of sulfanilic acid with
nitrite ions and the subsequent coupling of this product with diamine
(Guevara et al., 1998). This results in a measurable pink metabolite
with an absorption maximum of 540 nm. Griess reagent comprised
1% sulfanilamide (w/v), 3.5% phosphoric acid (v/v), and 0.1% beta-
naphthylethylene diamine dihydrochloride (w/v), in double-distilled
water.
Keratinocytes were pretreated for 24 hours with vehicle or
1,25(OH)2D3 diluted in cell culture media, then washed and
irradiated or sham-irradiated in buffer as described above. After
irradiation, known inhibitors of NO, L-N-monomethylarginine
(L-NMMA) (1.28 mM in buffer) and aminoguanidine (2 mM in buffer)
were added to the buffer solution and plates were incubated at 371C
for 30 minutes. An equal volume of Griess reagent was added to
supernatant from keratinocytes. Plates were incubated for 15 minutes
at room temperature, after which absorption at 550 nm was
determined using a FLUOstar Galaxy microplate reader (BMG
Labtechnologies (Mornington, Australia). The concentration of
sodium nitrite was interpolated from the linear portion of a standard
curve using sodium nitrite in double-distilled water as a reference.
Skh:hr1 hairless mice
All animal studies were approved by the Animal Ethics Committee of
the University of Sydney. Mice were maintained in wire-topped
plastic boxes at 23–251C on compressed paper bedding from
Fibrecycle Pty. Ltd (Mudgeeraba, Australia). Mice were fed Gordon
Rat and Mouse Pellets (Yandeera, Australia) and tap water ad
libitum. Mice were treated topically with vehicle only or
1,25(OH)2D3. Stock solutions of test compounds were dissolved in
ethanol and diluted in a base lotion containing propylene glycol and
water to a final solvent ratio of 2:1:1, respectively. Treatments were
applied dorsally, immediately after irradiation. Skin samples were
taken from UV-irradiated back skin 24 hours post-UVR, fixed,
processed, and paraffin-embedded, and sections subjected to routine
hematoxylin and eosin staining to visualize sunburn cells. The
stained sections were examined under a Zeiss-Axioplan light
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microscope at  40 original magnification, and the number of
sunburn cells recorded 1 per linear millimeter of skin. Immunohisto-
chemical analysis was also carried out for detection of TD. Sections
were de-paraffinized through graded alcohol and endogenous
peroxidase blocked by 3% H2O2 in H2O (v/v) for 5 minutes,
followed by antigen retrieval with citrate buffer in a microwave
oven for 15 minutes. Non-specific antibody blocking was achieved
using 10% normal horse serum in Tris-buffered saline. Sections were
incubated with the primary mouse monoclonal IgG1 anti-TD
antibody at a working concentration of 20 mg/ml in combination
with the Animal Research Kit (Dakocytomation) to minimize
reactivity of the anti-mouse antibody with any endogenous
immunoglobulin.
Statistical analysis
All experiments shown were repeated 2–6 times with similar results.
Data are presented either as a representative single experiment or as
normalized results from several pooled experiments. In each
experiment, values were based on 3–5 separate wells or 3–5 mice
per treatment group. Results are expressed as means7SD or 7SEM
as indicated. Significant differences were determined with one-way
analysis of variance followed by Dunnett’s test using a GraphPad
Instat statistical program (GraphPad Software Inc., San Diego, CA) or
by Student’s unpaired t-test where appropriate. Coefficients of
variation of percentage cell survival were calculated using the
coefficients of variation of each mean by the method of Colquhoun
(1971).
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SUPPLEMENTARY MATERIAL
Figure S1. 1,25(OH)2D3 increases keratinocyte survival after UVR in human
skin cells derived from the back of a female subject.
Figure S2. Increase in keratinocyte survival after UVR by 1,25(OH)2D3 but not
by inactive compound JB.
Figure S3. No correlation between 1,25(OH)2D3-antiproliferative effect and
improved cell survival after UV with 1,25(OH)2D3.
Figure S4. 1,25(OH)2D3-induced reduction in TDs after UVR in human
keratinocytes derived from the back of a female subject.
Figure S5. Reduction in keratinocyte TDs after UVR by 1,25(OH)2D3 but not
by inactive compound JB.
Figure S6. Further increase in UVR-induced p53 expression by 1,25(OH)2D3.
Figure S7. Output of UVR source used for in vitro studies.
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